LAVA Therapeutics N.V.

NASDAQ: LVTX · Real-Time Price · USD
1.52
-0.02 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
1.52
-0.33%
After-hours: Aug 15, 2025, 04:04 PM EDT

LAVA Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-25.11M -41.7M -31.66M -51.23M
Depreciation & Amortization
467K 612K 781K 632.61K
Stock-Based Compensation
3.23M 5.04M 4.11M 4.43M
Other Working Capital
5.95M -5.82M 32.7M 10.45M
Other Non-Cash Items
-2.5M -488K -3.06M 1.14M
Deferred Income Tax
-10K -279K -249K -177.99K
Change in Working Capital
4.38M -3.88M 34.11M 12.29M
Operating Cash Flow
-19.54M -38.97M 4.04M -32.48M
Capital Expenditures
-23K -731K -587K -866.15K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-97.09M -90.08M -70.88M -51.35M
Sales Maturities Of Investments
109.5M 73.18M 80.81M 2.85M
Other Investing Acitivies
88K n/a 9.28M -42.61M
Investing Cash Flow
12.47M -17.64M 9.35M -49.37M
Debt Repayment
-596K -571K 268K 340K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 15K n/a
Financial Cash Flow
-569K -571K 283K 171.37M
Net Cash Flow
-9.22M -56.1M 9.46M 85.09M
Free Cash Flow
-19.57M -41.01M 3.46M -33.34M